LTR Pharma Reports Full Year 2025 Earnings: AU$3.34 Loss per Share Compared to AU$0.05 Loss in FY 2024
Written by Emily J. Thompson, Senior Investment Analyst
Source: Yahoo Finance
Updated: Aug 31 2025
0mins
Source: Yahoo Finance
Financial Performance
- Net Loss: LTR Pharma reported a net loss of AU$5.59 million for the fiscal year 2024, which represents a 20% reduction compared to the previous year.
- Loss Per Share: The loss per share stands at AU$3.34.
Stock Performance
- Share Price Decline: LTR Pharma's shares have decreased by 9.3% over the past week.
Investment Considerations
- Warning Signs: The article highlights five warning signs regarding LTR Pharma, with one particularly concerning aspect that investors should be aware of.
Additional Information
- Quantum Computing Stocks: The article mentions 20 stocks that are working towards making quantum computing a reality, suggesting potential future investment opportunities.
- Disclaimer: The commentary is based on historical data and analyst forecasts, and it does not constitute financial advice or a recommendation to buy or sell stocks. Simply Wall St does not hold any positions in the mentioned stocks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
